Scarica l'app Stockscreener
4.38
3.10%
-0.14
Pre-mercato:
4.40
0.02
+0.46%
Precedente Chiudi:
$4.52
Aprire:
$4.43
Volume 24 ore:
751.53K
Relative Volume:
0.64
Capitalizzazione di mercato:
$350.75M
Reddito:
$129.42M
Utile/perdita netta:
$17.38M
Rapporto P/E:
21.44
EPS:
0.2043
Flusso di cassa netto:
$13.15M
1 W Prestazione:
-2.01%
1M Prestazione:
-12.22%
6M Prestazione:
-40.65%
1 anno Prestazione:
-38.14%
Intervallo 1D:
$4.315
$4.45
Intervallo di 1 settimana:
$4.16
$4.625
Portata 52W:
$4.16
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Nome
Niagen Bioscience Inc
Settore
Industria
Telefono
310-388-6706
Indirizzo
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
4.38 | 350.75M | 129.42M | 17.38M | 13.15M | 0.2043 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-08-16 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2019-10-16 | Iniziato | Oppenheimer | Outperform |
| 2019-02-14 | Iniziato | B. Riley FBR | Buy |
| 2017-11-27 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-25 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-01-03 | Iniziato | Rodman & Renshaw | Buy |
Mostra tutto
Niagen Bioscience Inc Borsa (NAGE) Ultime notizie
Skincare-Focused Innovation Labs - trendhunter.com
JPMorgan Chase & Co. Makes New $3.68 Million Investment in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen Bioscience soars 38% on blowout Q4 results - Investing.com
Tru Niagen gains traction with expert backing, Niagen Bioscience expands reach - Traders Union
Canaccord Lowers Niagen Bioscience, Inc. (NAGE) PT on Updated Forecasts Following Q4 Results - Insider Monkey
Aug Wrap: How do insiders feel about Niagen Bioscience IncMarket Weekly Review & Daily Entry Point Trade Alerts - baoquankhu1.vn
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpa World, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas - marketscreener.com
12 Penny Stocks with Insider Buying in 2026 - Insider Monkey
Niagen Bioscience And OneSpaWorld Launch Niagen IV Across Medi-Spa Clinics On Cruise Ships - marketscreener.com
Niagen Bioscience's (NAGE) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat
Niagen Bioscience partners with OneSpaWorld for cruise ship clinics - Investing.com
Niagen Bioscience partners with OneSpaWorld for cruise ship clinics By Investing.com - Investing.com UK
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas - Business Wire
Niagen Bioscience, Inc. (NASDAQ:NAGE) Short Interest Down 13.6% in March - MarketBeat
NAGE Technical Analysis | Trend, Signals & Chart Patterns | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience (NAGE) price target decreased by 13.92% to 13.87 - MSN
Niagen Bioscience (NASDAQ:NAGE) Upgraded at Wall Street Zen - MarketBeat
Q4 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
New Highs: How is Niagen Bioscience Inc managing supply chain issuesTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
How The Niagen Bioscience (NAGE) Story Is Shifting Around Price Targets And Injectables Potential - Yahoo Finance
Street Watch: Is Niagen Bioscience Inc stock risky to hold nowMarket Activity Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Niagen Bioscience doubles share buyback program to $20 million By Investing.com - Investing.com Canada
Niagen Bioscience Increases Share Repurchase Program to $20 Million - PharmiWeb.com
Niagen Bioscience Doubles Share Repurchase Authorization to $20M - TipRanks
Niagen Bioscience doubles share buyback program to $20 million - Investing.com
Niagen Bioscience raises share buyback authorization to $20M, $2.6M repurchased to date - TradingView
Niagen Bioscience (NAGE) boosts share repurchase authorization to $20 million - Stock Titan
Will Niagen Bioscience Inc outperform its industry peers2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Niagen Bioscience, Inc. announces an Increase in Equity Buyback. - marketscreener.com
Niagen Bioscience to Present at the 38th Annual ROTH Conference - PharmiWeb.com
Niagen Bioscience research program reaches 300 material agreements By Investing.com - Investing.com South Africa
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies - BioSpace
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Nia - PharmiWeb.com
Niagen Bioscience research program reaches 300 material agreements - Investing.com
National Advertising Division Recommends Niagen Update Tru Niagen NAD+ Claims - happi.com
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen - Business Wire
Latest NAGE NewsNiagen Bioscience Announces Pharmaceutical-... - Stock Titan
Decliners Report: What is the Moat Score of Niagen Bioscience Inc2026 Retail Activity & Safe Entry Momentum Tips - baoquankhu1.vn
National Advertising Division Recommends Niagen Modify or Discontinue Certain Tru Niagen NAD+ Claims; Niagen to Appeal - The Manila Times
Bank Watch: How correlated is Niagen Bioscience Inc to the S P5002026 Intraday Action & Low Drawdown Trading Strategies - baoquankhu1.vn
Analyst Calls: Can Niagen Bioscience Inc stock outperform in a bear marketRisk Management & Weekly Hot Stock Watchlists - baoquankhu1.vn
Chart Watch: Is Niagen Bioscience Inc stock risky to hold nowMarket Volume Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Niagen Bioscience (NAGE) Earnings Transcript - AOL.com
Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line - MSN
Niagen Bioscience Launches Niagen Skincare Innovation Lab - Happi | Household And Personal Products Industry
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and D - GuruFocus
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® - 巴士的報
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen - itemonline.com
Earnings call transcript: Niagen Bioscience’s Q4 2025 revenue grows 16% - Investing.com Nigeria
Niagen Bioscience Inc Azioni (NAGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):